Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

US$4.20
FV
75.0% undervalued intrinsic discount
371.30%
Revenue growth p.a.
6users have liked this narrative
0users have commented on this narrative
63users have followed this narrative
15 days ago author updated this narrative
US$177.34
FV
19.7% overvalued intrinsic discount
14.68%
Revenue growth p.a.
13users have liked this narrative
0users have commented on this narrative
41users have followed this narrative
Updated narrative
CA$26.79
FV
87.9% undervalued intrinsic discount
78.01%
Revenue growth p.a.
13users have liked this narrative
0users have commented on this narrative
36users have followed this narrative
15 days ago author updated this narrative

Community Investing Ideas

CH
Community Contributor

Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth

EBIT-margin trajectory: Historical: 2.3 % → 3.6 % (FY 22/23) ​, down to – 2 % (FY 23/24) ​, back to 3 % in Q1 24/25 ​ Forecast: Gradual recovery to 4–6 % by FY 25/26, reaching 6–8 % by FY 29/30 Revenue growth: Historical: + 70 % (FY 22/23) ​, + 30 % (FY 23/24) ​, + 27 % (Q1 24/25) ​ Forecast: ~ 15 % CAGR over the next five years (FY 24/25–29/30) Five-year share-price goal: Current fair value: € 8.5–9.0 per share Five-year target: € 14–15 per share (≈ 1.9 bn EUR market cap) Enterprise value (EV) outlook (DCF-based): Revenues rising to ~ 1.8 bn EUR by FY 29/30 EBIT of ~ 145 m EUR (8 % margin) → NOPAT ~ 102 m EUR FCF margin ~ 5 % → ~ 90 m EUR FCF Terminal-value multiple: EV/FCF = 15 → TV ~ 1.35 bn EUR Discounted EV: ≈ 1.18 bn EUR + net cash 0.69 bn EUR → ≈ 1.87 bn EUR → ~ 14.8 EUR/share Top risks: execution delays, margin pressure from competition, raw-material cost swings, subsidy uncertainty, heavy capex needs Narrative Outlook Over the next five years, thyssenkrupp nucera is poised to leverage its unique position at the intersection of mature Chlor-Alkali expertise and rapid Green-Hydrogen adoption. After a transitional phase in FY 23/24 with negative margins driven by upfront investments, the company’s shift toward series-manufactured AWE modules and high-growth project backlog supports a steady margin recovery.
View narrative
€14.40
FV
31.8% undervalued intrinsic discount
15.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
15 days ago author updated this narrative
CA$26.79
FV
87.9% undervalued intrinsic discount
78.01%
Revenue growth p.a.
13users have liked this narrative
0users have commented on this narrative
36users have followed this narrative
15 days ago author updated this narrative
€36.42
FV
6.4% undervalued intrinsic discount
11.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
19 days ago author updated this narrative
NOK 8.66
FV
33.7% undervalued intrinsic discount
10.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
19 days ago author updated this narrative
NOK 130.00
FV
16.7% undervalued intrinsic discount
15.07%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
19 days ago author updated this narrative